Pfizer to Cut R&D Jobs, Retreat from Heart-Drug Research

Pfizer, the Lipitor company, is largely abandoning research into new medicines for heart disease to focus on hard-to-treat diseases such as cancer, autoimmune disorders and Alzheimer's.